Year 2023 / Volume 115 / Number 5
Letter
Severe hepatitis E in an immunocompetent young female treated with ribavirin

269-270

DOI: 10.17235/reed.2022.9105/2022

Maria Azevedo Silva, André Ruge Gonçalves, Carina Leal, Liliana Eliseu,

Abstract
A healthy 24-year-old woman was admitted to the emergency department with acute hepatitis. She denied traveling, consumption of drugs, herbs, alcohol or medication other than the same oral contraceptive for years. The etiological work-up revealed positive Herpes Simplex Virus (HSV) 1+2 serology (IgG and IgM). Other viral serologies were negative, while Hepatitis E Virus (HEV) serology and viraemia were pending. Liver biopsy showed portal and lobular necroinflammatory activity without specific etiological findings. The remaining work-up was unremarkable. The patient developed jaundice. Acyclovir was started, considering a possible herpetic hepatitis, while waiting for HSV viraemia and immunohistochemistry in the liver biopsy, which later revealed to be negative. Despite therapy, hyperbilirubinemia and liver cytolysis worsened. At this point, HEV serology and viraemia came back positive. Ribavirin was started with rapid clinical and biochemical improvement. Liver enzymes were normal and HEV viraemia was negative after 12 weeks of ribavirin, remaining undetectable 3 months later.
Share Button
New comment
Comments
No comments for this article
References
1. Aspinall EJ, Couturier E, Faber M, et al. Hepatitis E virus infection in Europe: Surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015. Eurosurveillance. 2017.
2. Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis e in Southwest England: Natural history, complications and seasonal variation, and hepatitis e virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2008;784–90.
3. Manka P, Bechmann LP, Coombes JD, et al. Hepatitis E Virus Infection as a Possible Cause of Acute Liver Failure in Europe. Clin Gastroenterol Hepatol. 2015;1836-1842.
4. Péron JM, Abravanel F, Guillaume M, et al. Treatment of autochthonous acute hepatitis E with short-term ribavirin: A multicenter retrospective study. Liver Int. 2016;328–33.
5. Pischke S, Hardtke S, Bode U, et al. Ribavirin treatment of acute and chronic hepatitis E: A single-centre experience. Liver Int. 2013;722–6.
Related articles

Editorial

Orthohepevirus C as causal agent of acute hepatitis in Spain

DOI: 10.17235/reed.2022.8993/2022

Digestive Diseases Image

Emphysematous hepatitis: a very rare entity with a poor prognosis

DOI: 10.17235/reed.2021.7795/2021

Citation tools
Azevedo Silva M, Ruge Gonçalves A, Leal C, Eliseu L. Severe hepatitis E in an immunocompetent young female treated with ribavirin. 9105/2022


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1019 visits.
This article has been downloaded 84 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 30/07/2022

Accepted: 26/08/2022

Online First: 31/08/2022

Published: 05/05/2023

Article Online First time: 32 days

Article editing time: 279 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology